Why Marijuana Edibles Could Be Another Big Disappointment for the Industry

Hexo Corp (TSX:HEXO) may not have as big of an advantage as it had hoped in the edibles market despite securing a deal with a big beverage maker.

| More on:
Marijuana plant and cannabis oil bottles isolated

Image source: Getty Images

The edible marijuana market is launching in December, but it may not result in the boom that many are hoping or expecting for. Health Canada unveiled its plans for edibles and like its first launch of cannabis products, there will be some significant restrictions for cannabis companies.

Not only will advertising remain very limited, but it will create inefficiencies for companies that already make food products, as they’ll need a separate facility for cannabis edibles to avoid cross-contamination. Despite the concerns about restrictions on the industry, Bill Blair, who is responsible for the cannabis policy, said. “It’s not the government’s intention to promote the use of this drug, but rather to make it legally available in a well-regulated manner to reduce the social and health harms often associated with cannabis use.”

However, the danger is that by being so restrictive, it gives the black market a lot more power by providing consumers with more attractive and flexible options. One of the goals of marijuana legalization was to shift cannabis sales away from the underground. With cannabis prices already much more expensive and the difficulty of advertising and reaching consumers, it puts companies like Hexo Corp (TSX:HEXO) at a big disadvantage in relation to their U.S. counterparts.

While Hexo landed a deal with Molson Coors Canada, and although it will help the cannabis company develop infused beverages, it won’t be able to take advantage of its partner’s brand. Under the regulations, a cannabis product can’t be associated with an alcohol product. It negates one of the biggest potential benefits that cannabis companies had by linking up with successful beer makers: selling products with their popular logos.

Restrictive packing requirements means that Hexo won’t be able to have a co-branded product with Molson that can utilize the company’s image. It’s a big disadvantage for the company, especially when you look south of the border to states that have permitted cannabis where regulations are much looser, and companies can have a lot of freedom when it comes to advertising and marketing their products.

It’s no surprise that the industry has been doing so well there. With a much smaller population and more restrictions, the Canadian market looks much less appealing in comparison to its U.S. counterpart.

What this means for investors

From an investment standpoint, this tells me that even though Hexo may be one of the top cannabis companies in Canada, the better buy might be in the U.S., where there’s definitely a lot more growth potential for marijuana. The rollout of cannabis in Canada hasn’t been smooth, to say the least, and with many restrictions in place on edibles, it’s not going to get any better anytime soon.

These restrictions come with a liberal government in place that was strongly in favour of legalizing cannabis. We could see the industry throttled even further should conservatives get into power and try to impose even more requirements on companies.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »